Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT07026968
What this trial is testing

Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
CSPC Ouyi Pharmaceutical Co., Ltd. 815
Large-scale testing (Phase 3)Study completedNCT02104804
What this trial is testing

Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 953
Large-scale testing (Phase 3)Study completedNCT02926950
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 518
Testing effectiveness (Phase 2)Study completedNCT01649297
What this trial is testing

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 983
Testing effectiveness (Phase 2)Study completedNCT01011868
What this trial is testing

Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 494
Large-scale testing (Phase 3)Study completedNCT01545388
What this trial is testing

Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 337
Testing effectiveness (Phase 2)Ended earlyNCT00868790
What this trial is testing

The Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 118
Large-scale testing (Phase 3)Study completedNCT01084005
What this trial is testing

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 241
Testing effectiveness (Phase 2)Study completedNCT00482079
What this trial is testing

MK0431 in Patients With Type 2 Diabetes (0431-010)

Who this might be right for
Diabetes Mellitus, Type II
Merck Sharp & Dohme LLC 743
Large-scale testing (Phase 3)Study completedNCT01029886
What this trial is testing

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 912
Large-scale testing (Phase 3)Ended earlyNCT01477853
What this trial is testing

The Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 166
Large-scale testing (Phase 3)UnknownNCT03851432
What this trial is testing

Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sihuan Pharmaceutical Holdings Group Ltd. 390
Testing effectiveness (Phase 2)Study completedNCT00824616
What this trial is testing

Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 68
Large-scale testing (Phase 3)Ended earlyNCT03386344
What this trial is testing

Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 376
Large-scale testing (Phase 3)Study completedNCT01702298
What this trial is testing

Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 42
Testing effectiveness (Phase 2)Ended earlyNCT00479466
What this trial is testing

Dose-Range Finding Study for MK0893 (0893-008)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 342
Large-scale testing (Phase 3)Study completedNCT00528879
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 915
Large-scale testing (Phase 3)Study completedNCT02324569
What this trial is testing

A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 240
Large-scale testing (Phase 3)Study completedNCT00683657
What this trial is testing

Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 93
Post-approval studies (Phase 4)Study completedNCT01006590
What this trial is testing

Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 286
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation